Cubist Systematic Strategies’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$2.83M Buy
42,100
+29,200
+226% +$2.31M 0.01% 1337
2025
Q2
$1.13M Buy
12,900
+3,400
+36% +$267K 0.01% 1882
2025
Q1
$649K Sell
9,500
-6,000
-39% -$490K ﹤0.01% 2044
2024
Q4
$1.21M Sell
15,500
-69,200
-82% -$5.12M 0.01% 1685
2024
Q3
$5.68M Buy
84,700
+12,800
+18% +$1.05M 0.03% 760
2024
Q2
$8.15M Sell
71,900
-33,500
-32% -$4.24M 0.06% 517
2024
Q1
$14.6M Buy
105,400
+29,300
+39% +$3.68M 0.08% 311
2023
Q4
$9.44M Buy
76,100
+58,500
+332% +$5.98M 0.06% 485
2023
Q3
$1.64M Buy
17,600
+13,200
+300% +$1.49M 0.01% 1506
2023
Q2
$565K Buy
4,400
+1,000
+29% +$121K ﹤0.01% 2315
2023
Q1
$395K Buy
+3,400
New +$381K ﹤0.01% 2817
2022
Q4
Sell
-1,600
Closed -$129K 4319
2022
Q3
$129K Sell
1,600
-3,600
-69% -$305K ﹤0.01% 3932
2022
Q2
$388K Buy
+5,200
New +$475K ﹤0.01% 3251

Other funds holding DXCM

Cubist Systematic Strategies's DXCM Position: Q3 2025 in Review

Cubist Systematic Strategies opened a new position in DexCom (DXCM) in Q3 2025: 474,151 shares worth $31.9M. The stake represents 0.15% of the portfolio and ranks #142 among its holdings. This is a return to the name: Cubist Systematic Strategies previously reported a position in DXCM as recently as Q1 2025.

Cubist Systematic Strategies first reported a position in DXCM in Q2 2014 and has held it in 41 quarters since. 910 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.

  • Cubist Systematic Strategies held 474,151 shares of DexCom worth $31.9M as of Q3 2025.
  • DexCom was a new Cubist Systematic Strategies position in Q3 2025.
  • DexCom made up 0.15% of Cubist Systematic Strategies's portfolio in Q3 2025, its #142 holding.
  • Cubist Systematic Strategies first reported a position in DexCom in Q2 2014 and has held it in 41 quarters since.
  • 910 funds tracked by Wall St. Rank held DexCom as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.